Drug Topics
AUGUST 29, 2024
As research continues to uncover the potential benefits of psilocybin, pharmacists and other clinicians have an essential role in bridging ancient wisdom with contemporary science.
Pharmacy Times
AUGUST 29, 2024
Pharmacists can provide extra resources for patients, including explanations of the therapy options for the patients, the course of therapy, and what patients can expect.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
AUGUST 29, 2024
Stephanie Sober, MD, MSHP, investigator on the pivotal research that supported the prescription-to-OTC switch of Opill, shares insights on how the medicine is reshaping the reproductive landscape.
STAT
AUGUST 29, 2024
On Thursday, the California Department of Food and Agriculture announced it is investigating the possible introduction of H5N1 bird flu in cattle at three dairy farms in the Central Valley. If confirmed, they would be the first known cases in that state. In a statement, officials said testing of samples from the three farms is currently underway in the state’s veterinary diagnostic lab.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
AUGUST 29, 2024
Using 1 nicotine-containing electronic cigarette was significantly correlated with an increase in residual volume and total lung capacity in patients with asthma.
Fierce Pharma
AUGUST 29, 2024
A Merck & Co. effort to move its PD-1 behemoth Keytruda into early treatment of lung cancer has reached a dead end, along with another bid to expand into a type of early-stage skin cancer. | A Merck & Co. effort to move its PD-1 behemoth Keytruda into early treatment of lung cancer has reached a dead end, along with another bid to expand into a type of early-stage skin cancer.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
AUGUST 29, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey there. We await one of the year’s biggest biotech readouts, and have lots of GLP-1 news today: Eli Lilly’s offer to slash pricing for Zepbound isn’t as magnanimous as it appears, and more.
Pharmacy Times
AUGUST 29, 2024
The findings further the understanding of respiratory virus immune evasion mechanisms and uncover how RSV-NS1 can target therapeutic intervention
Fierce Healthcare
AUGUST 29, 2024
A key legislator is accusing the leaders of the three largest pharmacy benefit managers of making fraudulent statements during a hearing last month on the industry. | A key legislator is accusing the leaders of the three largest pharmacy benefit managers of making fraudulent statements during a hearing last month on the industry.
Pharmacy Times
AUGUST 29, 2024
Expert shares reasons why many women are behind on their annual breast cancer screenings, along with the latest cutting edge treatments in the breast cancer space.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Pharma
AUGUST 29, 2024
Despite competing against several drugs that have been approved to fend off migraine headaches, AbbVie’s Ubrelvy (ubrogepant) —which is approved only to treat them—has carved out a significant nich | Recent trial results indicate that AbbVie's migraine treatment Ubrelvy works as a preventative. In a study published this week in the journal Neurology, Ubrelvy was 73% more effective in preventing a migraine attack than placebo.
Pharmacy Times
AUGUST 29, 2024
Pharmacists support treatment adherence as well as monitor adverse effects, drug-drug interactions, and quality of life.
STAT
AUGUST 29, 2024
I dreamed of having children from a young age — so much so that I assumed I had to be a cisgender woman. Society had taught me that only a cisgender woman would want so badly to carry and birth a child, so I suppressed any feelings that suggested I might not be a cisgender woman. I did not realize I was transgender until well after I had my children.
Fierce Healthcare
AUGUST 29, 2024
As artificial intelligence tools make their way into hospitals and doctor's offices, Elation Health saw a big opportunity to leverage its expertise in building clinical-first tech to roll out AI pu | As artificial intelligence tools make their way into hospitals and doctor's offices, Elation Health saw a big opportunity to leverage its expertise in building clinical-first tech to roll out AI purpose-built for primary care doctors.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
The Checkup by Singlecare
AUGUST 29, 2024
Heartburn is incredibly common during pregnancy, especially in the second and third trimesters. If you find yourself dreading that churning, burning feeling before every meal, don’t fret. Pregnancy-safe treatments and remedies, such as famotidine (commonly known by its brand names Pepcid AC and Zantac 360 ), can help. Famotidine belongs to a class of medications called histamine-2 receptor antagonists ( H2 blockers for short).
pharmaphorum
AUGUST 29, 2024
Shares in Neurocrine Biosciences took a tumble after it reported mid-stage data for a key pipeline drug for schizophrenia that failed to impress investors
STAT
AUGUST 29, 2024
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. Labor Day is almost here, which means the sprint to the end of 2024 is upon us. If you’re reading this late-August newsletter from the beach, the pool, or the mountains, I thank you for it.
pharmaphorum
AUGUST 29, 2024
Digital health firm Curio raises $10m+ in first-round financing that will be used to fund the rollout of its MamaLift Plus app for postpartum depression
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
AUGUST 29, 2024
What’s behind the “great abandonment” in gene therapy R&D? How does a startup spend $213 million? And is Adam an optimist? We talk about all that and more on this week’s episode of “The Readout LOUD.” STAT biotech reporter Jonathan Wosen joins us to discuss gene therapy pioneer Jim Wilson’s exit from his decades-long tenure at the University of Pennsylvania.
Drug Topics
AUGUST 29, 2024
Results from the INTEGUMENT-OLE phase 3 trial showed the therapy was also well-tolerated, with no new safety signals observed during treatment of up to 56 weeks.
The Checkup by Singlecare
AUGUST 29, 2024
Around 1 in 10 Americans have some type of eczema , which means 10% of the country deals with dry, itchy, inflamed, scaly skin or lesions. Dupixent (dupilumab) is a biologic monoclonal antibody medication that can help treat moderate-to-severe atopic dermatitis (AD), as well as asthma, chronic rhinosinusitis, and nasal polyps. Although it can relieve some of this skin disease’s most irritating symptoms, dupilumab treatment may also cause side effects, specifically a facial rash and facial erythe
pharmaphorum
AUGUST 29, 2024
GSK gets EU approval for its RSV vaccine Arexvy in a younger age group, a potential leg-up in a market tussle with Pfizer and Moderna
Fierce Pharma
AUGUST 29, 2024
Active pharmaceutical ingredient maker Global Calcium has run afoul of FDA investigators on the heels of a recent inspection of the company’s factory in the Indian State of Tamil Nadu. | Following an inspection that ran from July 29 to Aug. 2, the FDA handed API maker Global Calcium a six-observation Form 483. The FDA’s writeup covers a range of production infractions, ranging from incomplete batch records and poorly followed manufacturing procedures to subpar testing and poor facility upkeep.
pharmaphorum
AUGUST 29, 2024
Novartis partners with startup Lindy in a near-$1bn deal to develop subcutaneous formulations of biologic drugs
Fierce Pharma
AUGUST 29, 2024
Sanofi has suspended distribution of its two flu vaccines in China out of concern of waning potency. BioNTech's antibody-drug conjugate partner, DualityBio, has filed for a Hong Kong IPO. | Sanofi has suspended distribution of its two flu vaccines in China. BioNTech's ADC partner, DualityBio, has filed for a Hong Kong IPO. UCB will offload some Chinese assets for $680 million.
pharmaphorum
AUGUST 29, 2024
Bayer takes oral anti-HER2 drug into phase 3 for HER2-altered lung cancer, a key pillar of its drive to become a major player in oncology
STAT
AUGUST 29, 2024
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in your inbox. Good morning and happy Thursday! Yesterday it was announced that my colleague Usha Lee McFarling won the 2024 Victor Cohn Prize for Excellence in Medical Science Reporting. I’m genuinely so honored to work in the same newsroom as Usha. Her stories — read them all — have elucidated so many under-covered, unresolved racial health inequities within in our health care syst
Pharmaceutical Commerce
AUGUST 29, 2024
Panel offers suggestions on how compliance teams should be considering handling SOPs, stabilization, and much more.
The Guardian - Pharmaceutical Industry
AUGUST 29, 2024
For years we’ve been told to use pharmacies rather than GPs whenever possible. The would be fine – if so many of them hadn’t closed down Until I’d woken up in the middle of an orchard at 2am with a child so covered in bites it was like trying to share a tent with a bag of feral cats, I hadn’t quite realised the extent of the pharmacy shortage in the UK.
pharmaphorum
AUGUST 29, 2024
Follow along on a journey from deep depression to mental health advocacy, discovering ways to cope and support others along the way.
Outsourcing Pharma
AUGUST 29, 2024
The European Commission has approved ARS Pharmaceuticalsâ adrenaline nasal spray for the emergency treatment of severe allergies, EURneffy.
pharmaphorum
AUGUST 29, 2024
Learn about drug repositioning, a strategy that involves finding new uses for existing drugs. Discover how this approach brings forgotten assets from shelves to patients and contributes to drug development.
Fierce Pharma
AUGUST 29, 2024
It’s been two years since the Inflation Reduction Act was passed, and while the law's Medicare-negotiated price cuts haven’t yet gone into effect, a change surrounding biosimilar reimbursement rate | The Inflation Reduction Act features a five-year boost in Medicare Part B reimbursement rates for biosimilars. The measure was intended to boost uptake, but has it worked so far?
Expert insights. Personalized for you.
232 
Let's personalize your content